Hexaell Biotech
Founded Year
2015Stage
Series C | AliveTotal Raised
$7.25MAbout Hexaell Biotech
Hexaell Biotech is a biopharmaceutical company focused on severe liver disease and cell therapy using cell differentiation and production technology. The company was founded in 2015 and is based in Shanghai, China.
Missing: Hexaell Biotech's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Hexaell Biotech's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Hexaell Biotech
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Hexaell Biotech is included in 2 Expert Collections, including Biopharma Tech.
Biopharma Tech
15,535 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Regenerative Medicine
1,818 items
Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).
Hexaell Biotech Frequently Asked Questions (FAQ)
When was Hexaell Biotech founded?
Hexaell Biotech was founded in 2015.
Where is Hexaell Biotech's headquarters?
Hexaell Biotech's headquarters is located at Building D, Shanghai.
What is Hexaell Biotech's latest funding round?
Hexaell Biotech's latest funding round is Series C.
How much did Hexaell Biotech raise?
Hexaell Biotech raised a total of $7.25M.
Who are the investors of Hexaell Biotech?
Investors of Hexaell Biotech include Lapam Capital, Wu Capital, ZJSTIC, Hengxu Capital, Sherpa Venture Capital and 4 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.